Jacob Steele

9PUBLICATIONS
113CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersHaematological tumoursTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 17, 2026
Control of naive T cell reactivity and peripheral tolerance by ascorbate and TET activity.

|Apr 19, 2026
Therapy-Related Mutational Signatures in Subsequent Neoplasms among Survivors of Childhood Cancer.

|Sep 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity.

Shivendra Singh, Jie Fang, Hongjian Jin

|May 06, 2025
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.

Jie Fang, Shivendra Singh, Brennan Wells

|Feb 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid.

Min Pan, Yinwen Zhang, William C Wright

|Jun 10, 2024
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.

Jun Yang, Jie Fang, Shivendra Singh

Pageof 2

Frequent Collaborators

8 joint publications

Shondra Pruett-Miller

5 joint publications

John Easton

4 joint publications

Qiong Wu

4 joint publications

Jun Yang